Brief: Alpha Tau Receives FDA Approval To Initiate A Trial For Patients With Recurrent Glioblastoma

Alpha Tau Medical

02/04/2025 14:07

April 2 (Reuters) - Alpha Tau Medical Ltd DRTS.O:

ALPHA TAU RECEIVES FDA APPROVAL TO INITIATE A TRIAL FOR PATIENTS WITH RECURRENT GLIOBLASTOMA

Source text: ID:nGNX9xf9q5

Further company coverage: DRTS.O

 (((( Reuters.briefs@thomsonreuters.com ;));))